VC · Visteon Corp
$88.77
+0.41 (+0.46%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$2.41B
Shares
26.70M
Volume · Oct 2
342.68K
Avg daily vol (3M)
472.59K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$88.77
Open$89.24
Day$87.10–89.24
52W close$84.45–123.90
Avg vol 30d494K
Short int4.1M · 15.3% float · 10.9d
Short vol46%
Last earningsJul 23, 2026
DataJan 2020–Oct 2026
Filing10-Q · Jul 23
Up next
Next earnings call
Oct 22, 2026
Est · unconfirmed
· in 3 wks
filed Jul 23, 2026
call held Jul 23, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$3.78B
Trailing 12 months
Net income (TTM)
$143.00M
Trailing 12 months
Revenue growth YoY
-0.9%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
17.0
Trailing earnings · reciprocal yield 5.9%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-1.4%
Year over year · fewer shares
Price change (1Y)
-27.4%
Trailing year
Short interest
15.3%
Latest settlement · 10.9 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
Death cross
Price vs 200-day avg
−13%
below
Price vs 50-day avg
−12%
below
RSI (14)
31
neutral
MACD trend
Negative
52-week position
11%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−13%
trailing
6-month return
−5%
trailing
YTD return
−7%
this year
Relative strength
−17%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Death cross
50d $100 › 200d $102 — 200d above 50d
Institutional flow
Accumulating
2 of 324 funds reported for Sep 30 · net +160 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
15.31% of float · ▲ +7.6% MoM · 10.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
324 holders — near 3-yr high, broad support
Squeeze score
79
high risk · 0–100
Fundamentals
Revenue growth
−3%
Y/Y
Gross margin
14%
expanding
EPS growth
−31%
Y/Y
Free cash flow
$268.0M
Valuation
P/E 17.4
below peers
Buyback
$800.0M
authorized
Balance sheet
$470.0M
net cash
Quant / Vol
risk profile
Volatility
39%
annualized · 1-yr
Max drawdown
−31%
past year
ATR
3.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jun 30, 2026
Adjusted EBITDA
· full-year
Non-GAAP
$455M – $495M
Guided vs delivered
· last 3 settled
Sales
full-year 2024
guided $3.85B – $3.95B
$3.87B
In line
Sales
full-year 2023
guided $3.95B – $4.03B
$3.95B
In line
Sales
2021
guided $2.88B – $3.03B
$2.77B
Miss −6.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
Death cross
Bearish
Price vs 200-day avg
−13%
Bearish
Price vs 50-day avg
−12%
Bearish
RSI (14)
31
Neutral
MACD trend
Negative
Bearish
52-week position
11%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
Death cross
50d $100 › 200d $102 — 200d above 50d
Institutional flow
Accumulating
2 of 324 funds reported for Sep 30 · net +160 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
15.31% of float · ▲ +7.6% MoM · 10.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
324 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $84
Now $89 · 11%
Range high $124
vs 200-day avg -13%
vs 50-day avg -12%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $116M | the three months ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Net income (loss) attributable to Visteon Corporation $49M
+$29M Depreciation and amortization
+$12M Non-cash, stock-based compensation expense
+$26M Provision for (benefit from) income taxes
-$1M Restructuring, net
-$3M Interest (income) expense, net
+$1M Net income (loss) attributable to non-controlling interests
-$2M Equity in net (income) loss of non-consolidated affiliates
+$5M Other
= Adjusted EBITDA $116M
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Auto Parts — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VC
this stock
Visteon Corp
|
$2.41B | -6.7% | -2.5% | 17.4 | 15.3% |
|
ORLY
O Reilly Automotive Inc
|
$69.66B | -6.9% | +6.4% | 27.3 | 3.2% |
|
AZO
Autozone Inc
|
$46.95B | -17.7% | +2.4% | — | 3.0% |
|
SMTOY
Sumitomo Electric Industries Ltd/Adr/
|
$43.43B | — | — | — | 0.0% |
|
HSAI
Hesai Group
|
$20.43B | -31.3% | +52.1% | — | 0.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VC | -1.9% | -13.2% | -5.0% | +2.4% | -6.7% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -1.7% | -12.7% | -17.2% | +1.5% | -19.5% |
Capital returns
Buyback program
· as of Jul 23, 2026
Authorized
$800.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1111335
CUSIP
92839U206
13F (30d)
14 filings
12 filers
Visit website
Investor relations